相关实验视频
Updated: May 1, 2026
07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
36.8K
技术上可行的解决方案,以应对在植入前遗传测试的thalassemia挑战:在2019年和2022年之间多个中心的经验
Zi Ren1,2,3, Peng Huang4, Yong Wang5
1Reproductive Medicine Center, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510655, China.
Journal of assisted reproduction and genetics
|September 10, 2024
概括
对单一性疾病的植入前遗传检测 (PGT-M) 已经得到了改善,克服了缺失的家庭数据等挑战. 这项研究通过创新的哈普洛型策略提高了PGT-M血病的成功率.
科学领域:
- 生殖医学 生殖医学
- 临床遗传学 临床遗传学
- 泰拉西米亚研究研究
背景情况:
- 对单一性疾病的植入前遗传检测 (PGT-M) 对于预防遗传性疾病至关重要.
- 之前的PGT-M对血病的检测面临着一些局限性,包括没有探针,不完整的家庭数据和检测失败.
- 应对这些挑战对于改善PGT-M在血病中的临床应用至关重要.
研究的目的:
- 开发和验证PGT-M中复杂情景的解决方案,用于thalassemia.
- 提高PGT-M对α-和β-thalassemia的成功率和可靠性.
- 为了克服缺少家族DNA样本或胚胎突变检测问题的局限性.
主要方法:
- 对342对夫妇进行阿尔法或β-thalassemia的PGT-M进行回顾性分析 (2019-2022).
- 使用多种DNA来源构建家长类型,包括试验者,父母,兄弟姐妹,单个精子和受影响的胚胎.
- 分析了1778个胚胎的染色体 ploidy 和 PGT-M 结果,并通过羊膜切割进行后续检查.
主要成果:
- 在确定哈普洛类型方面,总体成功率高达99.4% (340/342).
- 在alpha-thalassemia (93.8%) 和β-thalassemia (98.2%) 中,SNP单双类型分析的高一致率.
- 多重回火和循环式放大周期 (MALBAC) 显示,全基因组放大成功率高于MDA (98.8%对96.2%).
- 在99个案例中,通过羊膜切割检查100%证实了PGT-M结果.
结论:
- 确定了可行的解决方案,以挑战thalassemia中的PGT-M场景.
- 该研究为改善临床PGT-M成功率提供了有价值的见解.
- 改进的哈普洛型构造策略增加了PGT-M对单一性疾病的疗效.
相关概念视频
00:59Gene Therapy
22.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
01:22Bone Marrow Sampling and Transplants
3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K